Global Healthcare Company Celebrates Milestone For This Patent Approval

Unveiling Altamira Therapeutics' Breakthrough: European Patent for Intranasal Betahistine.

Altamira Therapeutics, a global biopharmaceutical company, is celebrating a significant milestone with the recent approval of their patent application by the European Patent Office (EPO) for their innovative product, Intranasal Betahistine. This news has stirred up excitement in the medical and investment communities alike, as it promises to accelerate …